Stephania Libreros, PhD, Receives NIH Pathway to Independence Award
Stephania Libreros, PhD, a newly appointed Assistant Professor of Pathology and a member of the Vascular Biology Therapeutics Program at Yale School of Medicine, was recently awarded a National Institute of Health (NIH) K99-R00 Award from National Heart Lung and Blood Institute, to support her independent research as she moves into a full-time tenure track faculty position.
Connecticut Academy of Science and Engineering Elects 35 New Members in 2023
East Hartford, CT —The Connecticut Academy of Science and Engineering (CASE) announces the election of 35 of Connecticut’s leading experts in science, technology, engineering, mathematics, and medicine to membership in the Academy. The new members will be introduced at the Academy’s 48th Annual Meeting and Dinner to be held at the Woodwinds in Branford on May 24, 2023.Source: Connecticut Academy of Science and Engineering
Carlos Fernández-Hernando, PhD, Appointed Director of Vascular Biology & Therapeutics Program at Yale School of Medicine
Carlos Fernández-Hernando, PhD, Anthony N. Brady Professor of Comparative Medicine and Pathology, was appointed as Director of the Vascular Biology & Therapeutics Program at Yale School of Medicine effective February 1.
Dr. Nassiri is selected to the International Society for Study of Vascular Anomalies (ISSVA) task force on classification of vascular anomalies
Dr. Nassiri is selected to represent the United States and the Specialty of Vascular Surgery on the International Society for Study of Vascular Anomalies (ISSVA) Ad-hoc Committee for Classification of Vascular Anomalies.Source: ISSVA Newsletter Vol 5 - No 1 | April 2021
The Yale Vascular Malformations Program (VaMP) identifies a culprit gene mutation implicated in the pathogenesis of "hepatic hemangiomas".
The Yale New Haven Hospital Vascular Malformations Program (VaMP), via a collaborative multidisciplinary effort, has identified somatic mosaic gene mutations (GJA4 encoding connexin 37) implicated in the pathogenesis of so-called “HEPATIC HEMANGIOMAS” in adult patients. This discovery questions the validity of the very term “hemangioma” in this particular anatomic distribution; and renders – for the first time - objective scientific support to the radiographically and clinically suspected notion that these lesions actually represent VENOUS MALFORMATIOMS - an entity with a completely different natural history, hemodynamics, angioarchitectural profile, and ergo therapeutic susceptibility.Source: Cutaneous and hepatic vascular lesions due to a recurrent somatic GJA4 mutation reveal a pathway for vascular malformation